BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 28565923)

  • 21. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of gastroenteritis in Australia: A healthcare perspective.
    Barker SF; Zomer E; O'Toole J; Sinclair M; Gibney K; Liew D; Leder K
    PLoS One; 2018; 13(4):e0195759. PubMed ID: 29649285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mental health service use: comparing people who served in the military or received Veterans' Affairs benefits and the general population.
    McGuire A; Dobson A; Mewton L; Varker T; Forbes D; Wade D
    Aust N Z J Public Health; 2015 Dec; 39(6):524-9. PubMed ID: 26337053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing.
    Teesson M; Hall W; Lynskey M; Degenhardt L
    Aust N Z J Psychiatry; 2000 Apr; 34(2):206-13. PubMed ID: 10789525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DSM-IV and DSM-5 social anxiety disorder in the Australian community.
    Crome E; Grove R; Baillie AJ; Sunderland M; Teesson M; Slade T
    Aust N Z J Psychiatry; 2015 Mar; 49(3):227-35. PubMed ID: 25122449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety disorders and cigarette smoking: Results from the Australian Survey of Mental Health and Wellbeing.
    Lawrence D; Considine J; Mitrou F; Zubrick SR
    Aust N Z J Psychiatry; 2010 Jun; 44(6):520-7. PubMed ID: 20482412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of first eye cataract surgery on mental health contacts for depression and/or anxiety: a population-based study using linked data.
    Meuleners LB; Hendrie D; Fraser ML; Ng JQ; Morlet N
    Acta Ophthalmol; 2013 Sep; 91(6):e445-9. PubMed ID: 23586972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term economic impacts of arthritis through lost productive life years: results from an Australian microsimulation model.
    Schofield D; Cunich M; Shrestha RN; Tanton R; Veerman L; Kelly S; Passey ME
    BMC Public Health; 2018 May; 18(1):654. PubMed ID: 29793478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services.
    Vos T; Haby MM; Magnus A; Mihalopoulos C; Andrews G; Carter R
    Aust N Z J Psychiatry; 2005 Aug; 39(8):701-12. PubMed ID: 16050924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Burden of Mental Illnesses in Pakistan.
    Malik MA; Khan MM
    J Ment Health Policy Econ; 2016 Sep; 19(3):155-66. PubMed ID: 27572143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cost-effectiveness of the Online MindSpot Clinic for the Treatment of Depression and Anxiety in Australia.
    Lee YC; Gao L; Dear BF; Titov N; Mihalopoulos C
    J Ment Health Policy Econ; 2017 Dec; 20(4):155-166. PubMed ID: 29300702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the number of adults with severe and persistent mental illness who have complex, multi-agency needs.
    Whiteford H; Buckingham B; Harris M; Diminic S; Stockings E; Degenhardt L
    Aust N Z J Psychiatry; 2017 Aug; 51(8):799-809. PubMed ID: 28718716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental illness and its effects on labour market outcomes.
    Cornwell K; Forbes C; Inder B; Meadows G
    J Ment Health Policy Econ; 2009 Sep; 12(3):107-18. PubMed ID: 19996474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking Status and Cost of Illness in Patients with Depressive Disorder Based on the National Health Survey in Spain.
    López Ibáñez de Aldecoa A; Cedillo Gómez S; Bruguera E; García-Portilla MP; Bobes J
    Subst Use Misuse; 2019; 54(5):713-723. PubMed ID: 30585110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The personal and national costs of early retirement because of spinal disorders: impacts on income, taxes, and government support payments.
    Schofield DJ; Shrestha RN; Percival R; Passey ME; Callander EJ; Kelly SJ
    Spine J; 2012 Dec; 12(12):1111-8. PubMed ID: 23092718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey.
    Harris MG; Baxter AJ; Reavley N; Diminic S; Pirkis J; Whiteford HA
    Epidemiol Psychiatr Sci; 2016 Dec; 25(6):548-561. PubMed ID: 26428069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative socioeconomic changes and mental disorders: a longitudinal study.
    Barbaglia MG; ten Have M; Dorsselaer S; Alonso J; de Graaf R
    J Epidemiol Community Health; 2015 Jan; 69(1):55-62. PubMed ID: 25205161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care costs associated with depressive and anxiety disorders in primary care.
    Simon G; Ormel J; VonKorff M; Barlow W
    Am J Psychiatry; 1995 Mar; 152(3):352-7. PubMed ID: 7864259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.